Evidence from two
double-blind, placebo-controlled trials
and one comparative trial suggest that cream made from the herb Oregon grape (
) may help reduce symptoms of psoriasis, although it does not seem to be as effective as standard medications.
In a double-blind study published in 2006, 200 people were given either a cream containing 10% Oregon grape extract or placebo twice a day for 3 months.
The results indicate that the people using Oregon grape experienced greater benefits than those in the placebo group, and the difference was statistically significant. The treatment was well tolerated; although, it caused rash or burning sensation in a few people.
Benefits were also seen in a double-blind, placebo-controlled study of 82 people with psoriasis.
However, the study design had a significant flaw: the treatment salve was darker in color than the placebo, possibly allowing participants to guess which was which.
Another study found that dithranol, a conventional drug used to treat psoriasis symptoms, was more effective than Oregon grape.
Regrettably, the authors fail to state whether this study was double-blind. Forty-nine participants applied one treatment to their left side and the other to their right for 4 weeks. Skin biopsies were then analyzed and compared with samples taken at the beginning of the study. The physicians evaluating changes in skin tissue were unaware which treatments had been used on the samples. Greater improvements were seen in the dithranol group.
in which 443 participants with psoriasis used Oregon grape topically for 12 weeks found the herb to be helpful for 73.7% of the group.
Without a placebo group, it's not possible to know whether Oregon grape was truly responsible for the improvement seen, but the trial does help to establish the herb's safety and tolerability.
Laboratory research suggests Oregon grape has some effects at the cellular level that might be helpful in psoriasis, such as slowing the rate of abnormal cell growth and reducing inflammation.
For more information, including dosage and safety issues, see the full